Literature DB >> 26398330

Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway.

Enjiao Zhang1, Zhenning Li1, Zhongfei Xu1, Weiyi Duan1, Changfu Sun1, Li Lu1.   

Abstract

Frizzled2 (Fzd2) is a receptor for wingless-type MMTV integration site family members (Wnts), the aberrant overexpression of which has been noted to contribute to cancer metastasis. The present study was performed to characterize the role of Fzd2 in the migration and invasion of oral squamous cell carcinomas (OSCC) in vitro. Using TSCCa cells (a tongue SCC cell line) for loss- or gain-of-function of Fzd2, we found that a forced overexpression of Fzd2 promoted TSCCa cell migration and invasion, decreased the expression of epithelial‑cadherin (E-cadherin, an epithelial marker) and increased that of vimentin, Snail Slug, matrix metalloproteinases (MMPs)-2/-9/-13 and a-disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS5). By contrast, RNA interference (RNAi)-mediated knockdown of Fzd2 had opposite effects on OSCC cells. In addition, we found that the phosphorylation of signal transducer and activator of transcription-3 (STAT3) was enhanced by Fzd2 overexpression, but suppressed by Fzd2 depletion, and that STAT3‑specific shRNA attenuated Fzd2 overexpression‑induced cell invasion. In summary, the present study demonstrated that Fzd2 contributes to the migration and invasion of OSCC cells, at least partly through regulation of the STAT3 pathway. These results suggest Fzd2 as a novel therapeutic target for OSCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26398330     DOI: 10.3892/or.2015.4285

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.

Authors:  Anthony D Saleh; Hui Cheng; Scott E Martin; Han Si; Pinar Ormanoglu; Sophie Carlson; Paul E Clavijo; Xinping Yang; Rita Das; Shaleeka Cornelius; Jamie Couper; Douglas Chepeha; Ludmila Danilova; Thomas M Harris; Michael B Prystowsky; Geoffrey J Childs; Richard V Smith; A Gordon Robertson; Steven J M Jones; Andrew D Cherniack; Sang S Kim; Antonina Rait; Kathleen F Pirollo; Esther H Chang; Zhong Chen; Carter Van Waes
Journal:  Clin Cancer Res       Date:  2019-02-05       Impact factor: 12.531

Review 2.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

Review 3.  Frizzled Receptors as Potential Therapeutic Targets in Human Cancers.

Authors:  Chui-Mian Zeng; Zhe Chen; Li Fu
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

4.  Caveolin-1 down-regulation is required for Wnt5a-Frizzled 2 signalling in Ha-RasV12 -induced cell transformation.

Authors:  Hsiu-Kuan Lin; Hsi-Hui Lin; Yu-Wei Chiou; Ching-Lung Wu; Wen-Tai Chiu; Ming-Jer Tang
Journal:  J Cell Mol Med       Date:  2018-03-04       Impact factor: 5.310

5.  FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma.

Authors:  Li Huang; Er-Ling Luo; Jing Xie; Rui-Huan Gan; Lin-Can Ding; Bo-Hua Su; Yong Zhao; Li-Song Lin; Da-Li Zheng; You-Guang Lu
Journal:  Int J Biol Sci       Date:  2019-08-24       Impact factor: 6.580

6.  FZD2 promotes TGF-β-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway.

Authors:  Dilihumaer Tuluhong; Tao Chen; Jingjie Wang; Huijuan Zeng; Hanjun Li; Wangmu Dunzhu; Qiurong Li; Shaohua Wang
Journal:  Cancer Cell Int       Date:  2021-04-08       Impact factor: 5.722

7.  Integrated weighted gene coexpression network analysis identifies Frizzled 2 (FZD2) as a key gene in invasive malignant pleomorphic adenoma.

Authors:  Zhenyuan Han; Huiping Ren; Jingjing Sun; Lihui Jin; Qin Wang; Chuanbin Guo; Zhen Tian
Journal:  J Transl Med       Date:  2022-01-05       Impact factor: 5.531

Review 8.  STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.

Authors:  Mingjing Jiang; Bo Li
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

9.  Analysis of the role of Frizzled 2 in different cancer types.

Authors:  Miaomiao Zhou; Xuezhu Sun; Yunhao Zhu
Journal:  FEBS Open Bio       Date:  2021-02-25       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.